Cytori Therapeutics, Inc. (CYTX) Tops Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts CYTX Hot Sheet
Price: $0.21 --0%
Financial Fact:
Cost of product revenues: 945K
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Cost of product revenues: 945K
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Cytori Therapeutics, Inc. (NASDAQ: CYTX) reported Q2 EPS of ($0.13), $0.01 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $4.4 million versus the consensus estimate of $2.46 million.
For earnings history and earnings-related data on Cytori Therapeutics, Inc. (CYTX) click here.
For earnings history and earnings-related data on Cytori Therapeutics, Inc. (CYTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ackman adds Netflix, Visa and Mastercard in portfolio revamp
- Forum Markets, Incorporated (FRMM) Tops Q2 EPS by 29c ; Offers Guidance
- Rekor Systems, Inc. (REKR) Tops Q2 EPS by 3c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
